Earnings History Data for Cellectar Biosciences, Inc. (CLRB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18-11-2024 | PM | CLRB | Cellectar Biosciences, Inc. | 81.54 | -0.55 | -0.34 | -0.82 | Cellectar Biosciences GAAP EPS of -$0.40 misses by $0.03 [11/18/2024 7:22 AM] |
1.76 | -0.10 (-5.11%) |
1.95 | 0.09 (4.84%) |
1.66 - 4.45 | 1,333,257 | 360,000 | 14,044 | ||
| 29-10-2024 | AH | CLRB | Cellectar Biosciences | 73.00 | -0.51 | -0.23 | 0.00 | 2.04 | -0.01 (-0.49%) |
2.01 | -0.04 (-1.94%) |
1.82 - 4.45 | 184,037 | 210,000 | 8,156 | |||
|
|
||||||||||||||||||
| 14-05-2024 | PM | CLRB | Cellectar Biosciences, Inc. | 99.04 | -0.40 | -0.50 | -0.76 | Cellectar Biosciences GAAP EPS of -$0.74 misses by $0.18 [5/14/2024 6:44 AM] |
3.18 | 0.12 (3.92%) |
3.07 | 0.01 (0.33%) |
1.36 - 4.45 | 629,641 | 640,000 | 32,848 | ||
| 27-03-2024 | PM | CLRB | Cellectar Biosciences, Inc. | 117.85 | -0.66 | -0.58 | -0.55 | Cellectar Biosciences GAAP EPS of -$3.11 misses by $0.28 [3/27/2024 6:47 AM] |
3.65 | -0.20 (-5.19%) |
3.85 | 0.0 (0.00%) |
1.30 - 4.45 | 1,418,498 | 1,150,000 | 22,247 | ||
| 13-11-2023 | PM | CLRB | Cellectar Biosciences | 19.00 | -0.82 | -0.44 | 0.00 | 2.07 | 0.13 (6.70%) |
0.0 | 0.0 (0.00%) |
1.25 - 3.15 | 256,607 | 190,000 | 0 | |||
|
|
||||||||||||||||||
| 04-05-2023 | PM | CLRB | Cellectar Biosciences | 15.00 | -0.76 | -0.75 | 0.00 | Cellectar Biosciences GAAP EPS of -$0.76 [5/4/2023 10:10 AM] |
1.48 | -0.03 (-1.99%) |
0.0 | 0.0 (0.00%) |
1.25 - 6.76 | 41,835 | 40,000 | 0 | ||
| 09-03-2023 | PM | CLRB | Cellectar Biosciences | 18.00 | -0.55 | -0.83 | 0.00 | Cellectar Biosciences GAAP EPS of -$4.05 misses by $0.74 [3/9/2023 8:59 AM] |
1.69 | -0.21 (-11.05%) |
0.0 | 0.0 (0.00%) |
1.25 - 7.90 | 86,969 | 150,000 | 0 | ||
| 03-11-2022 | PM | 8:30 AM ET (Nov 3) |
CLRB | Cellectar Biosciences | 12.00 | -1.28 | -1.21 | 0.00 | Cellectar Biosciences GAAP EPS of -$1.28 misses by $0.04 [11/3/2022 9:15 AM] |
1.96 | -0.08 (-3.92%) |
0.0 | 0.0 (0.00%) |
1.75 - 10.30 | 24,396 | 80,000 | 0 | |
| 05-08-2022 | PM | CLRB | Cellectar Biosciences | 28.00 | -1.22 | -1.08 | 0.00 | Cellectar Biosciences GAAP EPS of -$1.22 misses by $0.19 [8/5/2022 8:49 AM] |
5.11 | 0.11 (2.20%) |
4.89 | -0.11 (-2.20%) |
3.37 - 10.90 | 18,336 | 60,000 | 1,421 | ||
| 10-05-2022 | PM | CLRB | Cellectar Biosciences, Inc. | 29.93 | -0.10 | -0.11 | -0.13 | Cellectar Biosciences GAAP EPS of -$0.10 in-line [5/10/2022 8:52 AM] |
0.4010 | -0.04 (-8.15%) |
0.45 | 0.01 (3.07%) |
0.43 - 1.84 | 201,254 | 169,003 | 717 | ||
| 21-03-2022 | PM | CLRB | Cellectar Biosciences | 32.00 | -0.10 | -0.10 | 0.00 | Cellectar Biosciences GAAP EPS of -$0.43 beats by $0.01 [3/21/2022 8:39 AM] |
0.6228 | 0.08 (15.33%) |
0.5670 | 0.03 (5.00%) |
0.44 - 1.91 | 339,116 | 255,310 | 2,855 | ||
| 10-05-2021 | PM | CLRB | Cellectar Biosciences, Inc. | 72.00 | -0.13 | -0.09 | 0.00 | Cellectar Biosciences EPS beats by $0.03 [5/10/2021 8:44 AM] |
1.30 | -0.06 (-4.41%) |
1.35 | -0.01 (-0.73%) |
1.01 - 2.98 | 416,929 | 440,000 | 5,075 | ||
| 09-11-2020 | PM | 8:00 AM ET (Nov 9) |
CLRB | Cellectar Biosciences, Inc. | 31.42 | -0.15 | -0.15 | -0.42 | Cellectar Biosciences EPS beats by $0.05 [11/9/2020 8:52 AM] |
1.16 | 0.04 (3.57%) |
1.19 | 0.07 (6.25%) |
1.01 - 3.33 | 184,203 | 238,079 | 600 | |
|
|
||||||||||||||||||
| 10-08-2020 | PM | CLRB | Cellectar Biosciences, Inc. | 33.60 | -0.26 | -0.30 | -0.46 | Cellectar Biosciences EPS beats by $0.04 [8/10/2020 8:10 AM] |
1.41 | 0.0 (0.00%) |
1.43 | 0.02 (1.42%) |
1.01 - 3.33 | 254,460 | 1,758,553 | 8,829 | ||
|
|
||||||||||||||||||